IP Library Granted Patent US 7,101,682
Granted Patent B2
US 7,101,682 · App. 11/268,323 · Granted Sep 5, 2006

Simultaneous screening of multiple analytes

Assignee: Dade Behring Marburg GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,682
App. No.
11/268,323
Granted
Sep 5, 2006
Kind
B2
Abstract

Methods, compositions and kits are disclosed. The methods are directed to determining the presence of one or more analytes in a sample suspected of containing any one of a plurality of the analytes. A combination is provided comprising in a medium (i) the sample, (ii) a binding partner for each of the analytes, (iii) for each of the analytes, a first reagent comprising a member of a signal producing system, a ligand and an analyte analog, and (iv) a second reagent comprising a binding partner for the ligand. The binding of the binding partner for the ligand is affected by the presence of an analyte and alters the amount of signal produced by the member of the signal producing system. The signal thus is modulated if one or more of the analytes are present in the sample. The amount of the signal is determined and is related to the presence of one or more of the analytes in the sample. The method may be homogeneous or heterogeneous.

Claims (16)

1. A method for determining the presence of one or more analytes in a sample suspected of containing any of a plurality of said analytes, said method comprising:

(a) combining in a medium said sample and a binding partner for each of said analytes,

(b) adding to said combination, for each of said analytes, a first reagent that is a conjugate comprising a member of a signal producing system, a ligand and an analyte analog,

(c) adding to said combination a second reagent comprising a binding partner for said ligand, wherein the binding of said second reagent to said ligands alters the amount of signal produced by said member of a signal producing system if one or more of said analytes are present in said sample, and

(d) examining said medium for the amount of said signal, the amount thereof being related to the presence of one or more of said analytes in said sample.

2. A method according to claim 1 wherein said binding partner for each of said analytes is a protein.

3. A method according to claim 2 wherein said protein is an antigen or an antibody.

4. A method according to claim 1 wherein said ligand is a hapten.

5. A method according to claim 4 wherein said ligand is a small molecule selected from the group consisting of drugs, biotin and dyes.

6. A method according to claim 1 wherein said first reagent is bound to a matrix.

7. A method according to claim 1 wherein said second reagent is bound to a matrix.

8. A method according to claim 1 wherein said analyte is a drug.

9. A method according to claim 1 wherein said binding partner for said ligand is a protein.

10. A method according to claim 9 wherein said protein is an antigen or an antibody.

11. A method according to claim 1 wherein said member of a signal producing system is a label.

12. A method according to claim 11 wherein said label is selected from the group consisting of enzymes, dyes, fluorescent molecules, chemiluminescers, coenzymes and enzyme substrates.

Assignments (1)
CHANGE OF NAME Recorded Jun 21, 2010
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 024563/0503 →
Continuity (3)
Division 1088803300 · Jul 9, 2004
Division 0969138300 · Oct 17, 2000
Related Publication 20060099664A1 · May 11, 2006